Navigation Links
Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Date:7/19/2012

HAYWARD, Calif., July 19, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the pricing of an underwritten public offering of 33 million shares of its common stock, offered at a price of $1.00 per share.  The Company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Anthera, will be $33 million.  The offering is expected to close on or about July 24, 2012, subject to customary closing conditions.  In addition, Anthera has granted the underwriters a 30-day option to purchase up to an additional 4.95 million shares of common stock to cover over-allotments, if any.  The Company intends to use the net proceeds from the offering for general corporate purposes.

Piper Jaffray & Co. and Leerink Swann LLC are acting as joint book-running managers in the offering.  Canaccord Genuity is acting as lead manager in the offering.  Summer Street Research Partners is acting as co-manager in the offering.

The securities described above are being offered by the Company pursuant to a shelf registration statement previously filed with, and declared effective by, the Securities and Exchange Commission (the "SEC").   A final prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC's website at http://www.sec.gov.  Copies of the final prospectus supplement relating to these securities, when available, may be obtained from Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402 or by telephone at 800-747-3924 or by email at prospectus@pjc.com, or from Leerink Swann LLC, Attention: Syndicate Department, One Federal Street, 37th Floo
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
2. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
3. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
4. Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
6. Anthera Announces First Quarter 2012 Financial Report and Conference Call
7. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
8. The Franklin Institute Receives $2.5 Million Gift From Teva Pharmaceuticals
9. Empire Asset Management Co. Initiates Coverage on Transcept Pharmaceuticals Inc., (NASDAQ: TSPT)
10. Data Underscore Promise of Satori Pharmaceuticals Gamma-Secretase Modulator Program in Treatment of Alzheimers Disease
11. Ampio Pharmaceuticals Announces Closing of Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 Z-Medica, a leading ... has launched the first-ever line of products designed to ... line includes QuikClot ® EMS 4x4 Dressing, QuikClot ... EMS Rolled Gauze™, all custom-designed to help responders ... can be transported to a hospital or trauma center. ...
(Date:5/22/2013)... MAPLE GROVE, Minn. , May 22, ... today announced the successful completion of its ... (extended-release topiramate), an internally developed program for ... the company,s proprietary formulation technology.  USL255 is ... and reduce fluctuations in topiramate blood levels ...
(Date:5/22/2013)... 22, 2013   Life Line Screening  (LLS), ... today the creation of a unique partnership with ... MCM is a population health management organization. LLS ... of clients. These important expanded services will help MCM ... Effective prevention reduces cost of care when individuals are ...
Breaking Medicine Technology:Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2
... Feb. 2 The Robert C. Gallo Foundation ... appointment of Franco Nuschese as director of international ... his colleagues, who are internationally known for expertise ... also supports other organizations producing groundbreaking HIV research."It ...
... (NYSE: KR ) said today it is recalling ... in its family of stores because the products have the ... names in the 31 states where Kroger operates are included ... Less, Fry,s, King Soopers, Smith,s, Dillons, QFC, City Market, Foods ...
Cached Medicine Technology:Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research 2Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk 2Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk 3
(Date:5/22/2013)... A new study provides neurobiological evidence for ... in people with insomnia, which may have implications ... , "Insomnia has been consistently identified as a ... Franzen, PhD, an assistant professor of psychiatry at ... in the brain circuitry underlying emotion regulation may ...
(Date:5/22/2013)... married are less likely to be obese, according to ... Houston. , "Childhood obesity is a significant public health ... U.S. children ages 2-17 overweight or obese," said Rachel ... and director of Rice,s Kinder Institute Urban Health Program. ... explore the impact of family structure on this epidemic." ...
(Date:5/22/2013)... FL (PRWEB) May 22, 2013 Digital ... sweepstakes on behalf of its social media management client, ... win a year's supply of the all-natural organic deodorant. ... increase awareness of the rapidly-growing start-up deodorant company based ... up a contest or sweepstakes on a Facebook page ...
(Date:5/22/2013)... NJ) John Theurer Cancer Center at Hackensack University Medical ... will bring together leading cancer experts, for presentation and ... therapy and interventional immunology in oncology, on Friday, June ... to bring together some of the nation,s top immunology ... cell therapies in oncology, both in solid and liquid ...
(Date:5/22/2013)... OH (PRWEB) May 22, 2013 ... air quality merchandise ranging from furnace filters, dehumidifiers, ... is excited to add Stadler Form's product ... fashionable summer product line (fans, aroma diffusers and ... Stadler Form’s Otto Fan is the perfect combination ...
Breaking Medicine News(10 mins):Health News:Study shows that insomnia may cause dysfunction in emotional brain circuitry 2Health News:Children of married parents less likely to be obese 2Health News:Children of married parents less likely to be obese 3Health News:Social Media Management Firm, 21Digital, Launches National Facebook Sweepstakes for Client, Primal Pit Paste 2Health News:Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies 2Health News:DiscountFurnaceFilter.com Now Offers Stadler Form Products - Providing Solutions to All Your Summer Needs 2
... ... ... they entered? Normal age-related memory decline affects more than half of all seniors, and those over 80 ... program offered to older adults in their senior living communities helped improve their ability to recognize and ...
... agree that financial constraints and an aging population will require ... find that pushing back the eligibility age could be a ... most. The consequences both positive and negative of ... presented in the latest installment of the Public Policy & ...
... Medical Center have enrolled the first patient in Michigan ... the safety and effectiveness of the Moxy Drug Coated ... Thomas Davis, M.D., SJH&MC interventional cardiologist performed the case. ... manufacturer Lutonix, Inc., is the first drug-coated balloon pivotal ...
... , MONDAY, Aug. 29 (HealthDay News) -- Toddlers with ... developing asthma by the time they,re 12, new research suggests. ... of allergies who were followed from birth to age 12. The ... and 1 and 2 years to check for sensitivity to different ...
... Ga. The most common breast cancer uses the ... cells and blocking that system kills it, researchers report. ... new options for patients, particularly those resistant to standard ... said. Human estrogen receptor-positive breast cancer cells ...
... the EVATEL (EVAluation of TELe follow-up) trial are the ... benefits from the remote follow-up of ICD patients. The ... of the French Ministry for Health and independent of ... devices routinely implanted in patients at risk of sudden ...
Cached Medicine News:Health News:UCLA memory fitness program improves memory abilities of oldest adults 2Health News:UCLA memory fitness program improves memory abilities of oldest adults 3Health News:Aging authorities differ on tweaks to Social Security's benefit structure 2Health News:St. John Hospital 1st in Michigan to enroll patient in worldwide drug-coated balloon trial 2Health News:Research aims to starve breast cancer cells 2Health News:Potential benefits of remote follow-up of ICD patients 2
... the highest g-force ever. But optimal productivity ... Optima MAX combines maximum force, capacity, and ... that's worlds apart from any other system. ... enhanced efficiency, Optima takes productivity to the ...
... generating 694,000 x g at ... Beckman Coulter's Optima L-90K Ultracentrifuge ... separations in less time. This ... a broad range of superb ...
... With the ability to provide a simple, ... in lipemic samples), the Airfuge CLS delivers ... can be cleaned in 10 minutes, eliminating ... tabletop centrifuge: Reaches top speed in as ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: